Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126077301 | 12607730 | 1 | I | 20141128 | 20160729 | 20160729 | EXP | FR-MYLANLABS-2014M1013660 | MYLAN | LIABEUF S, GRAS V, MORAGNY J, DURAND-MAUGARD C, MASMOUDI K, ANDREJAK M. TROSPIUM CHLORIDE FOR OVERACTIVE BLADDER MAY INDUCE CENTRAL NERVOUS SYSTEM ADVERSE EVENTS. EUR-GERIATR-MED 2014; 5(3) 220-224 | 0.00 | Y | 0.00000 | 20160729 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126077301 | 12607730 | 1 | PS | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | DOSAGE NOT STATED | U | U | 76578 | ||||||||
| 126077301 | 12607730 | 2 | SS | DIGOXIN. | DIGOXIN | 1 | Unknown | DOSAGE NOT STATED | U | U | 0 | ||||||||
| 126077301 | 12607730 | 3 | SS | CERIS | TROSPIUM CHLORIDE | 1 | Oral | 20 MG/DAY | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126077301 | 12607730 | 3 | Hypertonic bladder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126077301 | 12607730 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126077301 | 12607730 | Bradycardia | |
| 126077301 | 12607730 | Confusional state | |
| 126077301 | 12607730 | Hallucination |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |